PTC THERAPEUTICS

ptc-therapeutics-logo

PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and small-molecule drugs. It offers Ataluren, an orally administered small-molecule investigational new drug for the treatment of cystic fibrosis and duchenne muscular dystrophy caused by nonsense mutations. The company also provides PTC299, an anti-angiogenesis drug for the treatment of metastatic breast cancer, multiple tumors, and neurofibromatosis. Its products are used for the treatment of genetic disorders, oncology, and infectious diseases. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.
#SimilarOrganizations #People #Financial #Event #Website #More

PTC THERAPEUTICS

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Therapeutics

Founded:
1998-01-01

Address:
South Plainfield, New Jersey, United States

Country:
United States

Website Url:
http://www.ptcbio.com

Total Employee:
101+

Status:
Active

Contact:
9082227231

Email Addresses:
[email protected]

Total Funding:
568.05 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Sitelinks Search Box Microsoft Exchange Online


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

keros-therapeutics-logo

Keros Therapeutics

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.


Current Advisors List

robert-schneider_image

Robert Schneider Member of the Scientific Advisory Board @ PTC Therapeutics
Advisor

not_available_image

Allan Jacobson Director @ PTC Therapeutics
Board_member
1998-01-01

eric-jacobsen_image

Eric Jacobsen Member of the Scientific Advisory Board @ PTC Therapeutics
Advisor

not_available_image

Michael Schmertzler Chairman of the Board of Directors @ PTC Therapeutics
Board_member
2001-01-01

not_available_image

Marvin Wickens Member of the Scientific Advisory Board @ PTC Therapeutics
Advisor

not_available_image

Jerome Zeldis Member of the Board of Directors @ PTC Therapeutics
Board_member
2012-09-01

ronald-renaud_image

Ronald Renaud Member of the Board of Directors @ PTC Therapeutics
Board_member

adam-koppel_image

Adam Koppel Member of the Board of Directors @ PTC Therapeutics
Board_member
2013-03-01

Current Employees Featured

peter-p-giannousis_image

Peter P. Giannousis
Peter P. Giannousis Vice President Technical Operations @ PTC Therapeutics
Vice President Technical Operations
2019-10-01

mary-frances-harmon_image

Mary Frances Harmon
Mary Frances Harmon Senior VP, Corporate Relations @ PTC Therapeutics
Senior VP, Corporate Relations
2017-05-01

mary-ann-johnston_image

Mary Ann Johnston
Mary Ann Johnston VP, Global Project Lead @ PTC Therapeutics
VP, Global Project Lead
2021-09-01

matthew-klein_image

Matthew Klein
Matthew Klein Chief Development Officer @ PTC Therapeutics
Chief Development Officer
2020-04-01

kylie-okeefe_image

Kylie O&s;Keefe
Kylie O'Keefe Senior Vice President, Head of Global Commercial and Corporate Strategy @ PTC Therapeutics
Senior Vice President, Head of Global Commercial and Corporate Strategy
2021-03-01

stuart-peltz_image

Stuart Peltz
Stuart Peltz CEO @ PTC Therapeutics
CEO
1998-03-01

dhaval-patel_image

Dhaval Patel
Dhaval Patel Senior Director & Head, Formulation Development @ PTC Therapeutics
Senior Director & Head, Formulation Development
2020-07-01

eric-pauwels_image

Eric Pauwels
Eric Pauwels Chief Business Officer @ PTC Therapeutics
Chief Business Officer
2020-04-01

neil-almstead_image

Neil Almstead
Neil Almstead Executive Vice President Research, Pharmaceutical Operations and Technology @ PTC Therapeutics
Executive Vice President Research, Pharmaceutical Operations and Technology
2015-01-01

mark-e-boulding_image

Mark E. Boulding
Mark E. Boulding Executive Vice President & Chief Legal Officer @ PTC Therapeutics
Executive Vice President & Chief Legal Officer
2002-04-01

Founder


not_available_image

Allan Jacobson

stuart-peltz_image

Stuart Peltz

Stock Details


Company's stock symbol is NASDAQ:PTCT

Acquisitions List

Date Company Article Price
2020-05-06 Censa Pharmaceuticals Censa Pharmaceuticals acquired by PTC Therapeutics N/A
2019-10-25 BioElectron Technology Corporation BioElectron Technology Corporation acquired by PTC Therapeutics 210 M USD
2018-07-19 Agilis Biotherapeutics Agilis Biotherapeutics acquired by PTC Therapeutics 200 M USD

Investors List

jennison-associates_image

Jennison Associates

Jennison Associates investment in Private Equity Round - PTC Therapeutics

vulcan-capital_image

Vulcan Capital

Vulcan Capital investment in Private Equity Round - PTC Therapeutics

adage-capital-management_image

Adage Capital Management

Adage Capital Management investment in Private Equity Round - PTC Therapeutics

delphi-ventures_image

Delphi Ventures

Delphi Ventures investment in Private Equity Round - PTC Therapeutics

brookside-capital_image

Brookside Capital

Brookside Capital investment in Private Equity Round - PTC Therapeutics

novo-a-s_image

Novo Holdings

Novo Holdings investment in Private Equity Round - PTC Therapeutics

longwood-founders-fund_image

Longwood Fund

Longwood Fund investment in Private Equity Round - PTC Therapeutics

credit-suisse_image

Credit Suisse

Credit Suisse investment in Private Equity Round - PTC Therapeutics

novo-a-s_image

Novo Holdings

Novo Holdings investment in Private Equity Round - PTC Therapeutics

credit-suisse_image

Credit Suisse

Credit Suisse investment in Private Equity Round - PTC Therapeutics

Investments List

Date Company Article Money raised
2020-01-13 ClearPoint Neuro PTC Therapeutics investment in Post-IPO Equity - ClearPoint Neuro 17.5 M USD

Newest Events participated

orphandrug-congress-usa-2017_event_image Participated in OrphanDrug Congress USA 2017 on 2017-04-19 as sponsor

the-conference-of-things-manufacturing_event_image Participated in The Conference of Things Manufacturing on 2015-11-26 as sponsor

Key Employee Changes

Date New article
2020-04-17 PTC Therapeutics elevates biotech buyout CEO to chief development officer

Official Site Inspections

http://www.ptcbio.com Semrush global rank: 1.35 M Semrush visits lastest month: 21.46 K

  • Host name: 23.185.0.4
  • IP address: 23.185.0.4
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "PTC Therapeutics" on Search Engine

dfkcompany.com © 2022. All rights reserved